相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Androgens and endometrium: New insights and new targets
Ioannis Simitsidellis et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Sexual steroid hormone receptors profiles of ovarian carcinoma in Mexican women
Maria J. Gomora et al.
ENDOCRINE CONNECTIONS (2018)
Machine learning predicts individual cancer patient responses to therapeutic drugs with high accuracy
Cai Huang et al.
SCIENTIFIC REPORTS (2018)
The role of biomarkers in the management of epithelial ovarian cancer
Wei-Lei Yang et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2017)
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
Zuguang Gu et al.
BIOINFORMATICS (2016)
Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panel
Benjamin C. Thomas et al.
ENDOCRINE-RELATED CANCER (2016)
The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer
Greg L. Shaw et al.
EUROPEAN UROLOGY (2016)
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers
Arash Salmaninejad et al.
IMMUNOLOGICAL INVESTIGATIONS (2016)
Identification of proteomic and metabolic signatures associated with chemoresistance of human epithelial ovarian cancer
Wenjuan Wu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Androgen Control in Prostate Cancer
Vasiliki Pelekanou et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
KeyPathwayMinerWeb: online multi-omics network enrichment
Markus List et al.
NUCLEIC ACIDS RESEARCH (2016)
Why have ovarian cancer mortality rates declined? Part II. Case-fatality
Victoria Sopik et al.
GYNECOLOGIC ONCOLOGY (2015)
Why have ovarian cancer mortality rates declined? Part III. Prospects for the future
Victoria Sopik et al.
GYNECOLOGIC ONCOLOGY (2015)
Why have ovarian cancer mortality rates declined? Part I. Incidence
Victoria Sopik et al.
GYNECOLOGIC ONCOLOGY (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
NbClust: AnRPackage for Determining the Relevant Number of Clusters in a Data Set
Malika Charrad et al.
Journal of Statistical Software (2015)
Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells
Loredana Alberti et al.
PLOS ONE (2015)
Expression analysis of BORIS during pluripotent, differentiated, cancerous, and non-cancerous cell states
Sara Soltanian et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2014)
High Expression of hTERT and Stemness Genes in BORIS/CTCFL Positive Cells Isolated from Embryonic Cancer Cells
Loredana Alberti et al.
PLOS ONE (2014)
Expression of the Cancer-Testis Antigen BORIS Correlates With Prostate Cancer
Zubair Cheema et al.
PROSTATE (2014)
Gene expression analysis in ovarian cancer - faults and hints from DNA microarray study
Katarzyna Marta Lisowska et al.
FRONTIERS IN ONCOLOGY (2014)
TGF-β Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment
Tsz-Lun Yeung et al.
CANCER RESEARCH (2013)
BORIS, Brother of the Regulator of Imprinted Sites, Is Aberrantly Expressed in Hepatocellular Carcinoma
Kefei Chen et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2013)
Simultaneous isolation of high-quality DNA, RNA, miRNA and proteins from tissues for genomic applications
Samuel Pena-Llopis et al.
NATURE PROTOCOLS (2013)
NCBI GEO: archive for functional genomics data sets-update
Tanya Barrett et al.
NUCLEIC ACIDS RESEARCH (2013)
Expression of Cancer/Testis Antigens is Correlated with Improved Survival in Glioblastoma
Marcelo Roberto Pereira Freitas et al.
ONCOTARGET (2013)
The sva package for removing batch effects and other unwanted variation in high-throughput experiments
Jeffrey T. Leek et al.
BIOINFORMATICS (2012)
HTRIdb: an open-access database for experimentally verified human transcriptional regulation interactions
Luiz A. Bovolenta et al.
BMC GENOMICS (2012)
Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer
Koji Okabayashi et al.
CANCER SCIENCE (2012)
ZNF385B and VEGFA Are Strongly Differentially Expressed in Serous Ovarian Carcinomas and Correlate with Survival
Bente Vilming Elgaaen et al.
PLOS ONE (2012)
BORIS Binding to the Promoters of Cancer Testis Antigens, MAGEA2, MAGEA3, and MAGEA4, Is Associated with Their Transcriptional Activation in Lung Cancer
Sheetal Bhan et al.
CLINICAL CANCER RESEARCH (2011)
Coordinated Cancer Germline Antigen Promoter and Global DNA Hypomethylation in Ovarian Cancer: Association with the BORIS/CTCF Expression Ratio and Advanced Stage
Anna Woloszynska-Read et al.
CLINICAL CANCER RESEARCH (2011)
miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
Bogdan Mateescu et al.
NATURE MEDICINE (2011)
BORIS/CTCFL-mediated transcriptional regulation of the hTERT telomerase gene in testicular and ovarian tumor cells
Stephanie Renaud et al.
NUCLEIC ACIDS RESEARCH (2011)
Activation of Phosphatidylcholine Cycle Enzymes in Human Epithelial Ovarian Cancer Cells
Egidio Iorio et al.
CANCER RESEARCH (2010)
The Structural Complexity of the Human BORIS Gene in Gametogenesis and Cancer
Elena M. Pugacheva et al.
PLOS ONE (2010)
A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2
Samuel C. Mok et al.
CANCER CELL (2009)
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2009)
PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas
Celestine S. Tung et al.
MODERN PATHOLOGY (2009)
Selective apoptosis of breast cancer cells by siRNA targeting of BORIS
Christopher J. Dougherty et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours
V. D'Arcy et al.
BRITISH JOURNAL OF CANCER (2008)
BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma
DI Loukinov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
分享论文
